Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017: Featured updates to the NCCN guidelines

Published

Journal Article (Review)

© JNCCN-Journal of the National Comprehensive Cancer Network. The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Guidelines focus on syndromes associated with an increased risk of breast and/ or ovarian cancer. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. The NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding risk management for carriers of moderately penetrant genetic mutations associated with breast and/or ovarian cancer.

Cited Authors

  • Daly, MB; Pilarski, R; Berry, M; Buys, SS; Farmer, M; Friedman, S; Garber, JE; Kauff, ND; Khan, S; Klein, C; Kohlmann, W; Kurian, A; Litton, JK; Madlensky, L; Merajver, SD; Offit, K; Pal, T; Reiser, G; Shannon, KM; Swisher, E; Vinayak, S; Voian, NC; Weitzel, JN; Wick, MJ; Wiesner, GL; Dwyer, M; Darlow, S

Published Date

  • January 1, 2017

Published In

Volume / Issue

  • 15 / 1

Start / End Page

  • 9 - 20

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

International Standard Serial Number (ISSN)

  • 1540-1405

Citation Source

  • Scopus